Takeda announces executive leadership changes
According to Takeda, its new strategic leadership changes will ensure…
According to Takeda, its new strategic leadership changes will ensure the continued growth and competitiveness of the company.
List view / Grid view
According to Takeda, its new strategic leadership changes will ensure…
According to Takeda, its new strategic leadership changes will ensure the continued growth and competitiveness of the company.
The pharmaceutical industry saw some notable mergers and acquisitions in…
The pharmaceutical industry saw some notable mergers and acquisitions in 2019; this article lists the top 10 by transaction size.
New extension of Synflorix vaccine supply agreement will help protect…
29 July 2013 | By GlaxoSmithKline
New extension of Synflorix vaccine supply agreement will help protect an additional 80 million children...
GSK has acquired Okairos AG, a specialist developer of vaccine…
29 May 2013 | By GlaxoSmithKline
GSK has acquired Okairos AG, a specialist developer of vaccine platform technologies for €250 million in cash...
GSK's new commitment to the GAVI Alliance...
9 May 2013 | By GlaxoSmithKline
GSK's new commitment to the GAVI Alliance...
GSK and Biological E. announced an agreement to form a…
28 January 2013 | By GlaxoSmithKline
GSK and Biological E. announced an agreement to form a 50/50 joint venture...
GSK welcomes the announcement from GAVI Alliance...
9 October 2012 | By GlaxoSmithKline
GSK welcomes the announcement from GAVI Alliance...
GSK has signed an agreement with Daiichi Sankyo Co., Ltd.…
1 March 2012 | By GlaxoSmithKline
GSK has signed an agreement with Daiichi Sankyo Co., Ltd. to form a Joint Venture...